TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer: clinical trial protocol - Kabirian, Rayan; Tredan, Olivier; Marmé, Frederik; Paoletti, Xavier; Eberst, Lauriane; Lebreton, Coriolan; La Motte Rouge, Thibault De; Sabatier, Renaud; Angelergues, Antoine; Fabbro, Michel; Gorp, Toon Van; Mansi, Laura; et al. (Future oncology, 2024)
Online veröffentlicht: 19. August 2024